Literature DB >> 20034972

Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

Thomas Sehestedt1, Jørgen Jeppesen, Tine W Hansen, Kristian Wachtell, Hans Ibsen, Christian Torp-Pedersen, Christian Torp-Petersen, Per Hildebrandt, Michael H Olsen.   

Abstract

AIMS: It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. METHODS AND
RESULTS: In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% CI 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR > or = 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE > or = 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE > or = 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE > or = 5% to include subjects with 1% < or = SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07).
CONCLUSION: Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034972     DOI: 10.1093/eurheartj/ehp546

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  56 in total

Review 1.  Hypertension in 2010: Blood pressure and the kidney.

Authors:  Luis M Ruilope
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

Review 2.  Isolated nocturnal hypertension and subclinical target organ damage: a systematic review of the literature.

Authors:  Anne Marie O'Flynn; Jamie M Madden; Audrey J Russell; Ronan J Curtin; Patricia M Kearney
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

Review 3.  Global Cardiovascular Risk Assessment: Strengths and Limitations.

Authors:  Josep Redon
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-03-18

4.  The role of urinary renalase on early-stage renal damage in Chinese adults with primary hypertension.

Authors:  Na-Na You; Wei-Hong Jiang; Ming-Yuan Lin; Xiao-Gang Li; Yu-Yan Wu; Jia-Ying Li; Xiao-Yu Zhou; Ze-Wen Ding; Jun-Wen Wang; Xie-Xiong Zhao; Hui-Ling Chen; Hui-Ting Tang
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

5.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

6.  Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters.

Authors:  Tolga Akkan; Mustafa Altay; Yasemin Ünsal; Murat Dağdeviren; Esin Beyan
Journal:  Endocrine       Date:  2017-10-17       Impact factor: 3.633

Review 7.  Early chronic kidney disease: diagnosis, management and models of care.

Authors:  Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

Review 8.  Salt controls endothelial and vascular phenotype.

Authors:  Kristina Kusche-Vihrog; Boris Schmitz; Eva Brand
Journal:  Pflugers Arch       Date:  2014-11-26       Impact factor: 3.657

9.  New cardiovascular risk factors and their use for an accurate cardiovascular risk assessment in hypertensive patients.

Authors:  Oana-Florentina Tautu; Roxana Darabont; Sebastian Onciul; Alexandru Deaconu; Ioana Comanescu; Radu Dan Andrei; Bogdan Dragoescu; Mircea Cinteza; Maria Dorobantu
Journal:  Maedica (Buchar)       Date:  2014-06

10.  An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.

Authors:  Yasemin Aydoğan; Mustafa Altay; Oktay Ünsal; Veysel Kaplanoğlu; Yavuz Çağır; Canan Yıldız; Esin Beyan; Selma Uysal Ramadan
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.